PMID- 12807723 OWN - NLM STAT- MEDLINE DCOM- 20030822 LR - 20210319 IS - 0143-3334 (Print) IS - 1460-2180 (Electronic) IS - 0143-3334 (Linking) VI - 24 IP - 7 DP - 2003 Jul TI - Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model. PG - 1183-90 AB - As there has been no previous information on the consequences of telomerase expression in genetically altered, mortal cells derived from pre-malignant tissue, we sought to determine the effect of hTERT (human catalytic subunit of telomerase reverse transcriptase) transduction of pre-malignant cell strains from Barrett's esophagus that do not contain telomerase activity and possess a finite lifespan. Primary cultures of Barrett's esophageal epithelium transduced with a retrovirus containing hTERT were characterized by growth factor requirements, cytogenetics and flow cytometry. Expression of telomerase lengthened telomeres and greatly extended the lifespan of hTERT transduced (hTERT+) Barrett's esophagus cells. Growth factor dependency of the hTERT+ cultures remained largely similar to the parental cultures, although there was a modest increase in the ability to grow in agar. Chromosomal instability, measured by both karyotypic and FISH (fluorescence in situ hybridization) analyses, was reduced but not abrogated by hTERT transduction, suggesting that telomerase expression can enhance genomic stability. However, the persistence of residual instability gave rise to new clonal and non-clonal genetic variants, and in one hTERT+ culture a new DNA aneuploid population was observed, the only time such a ploidy shift has been seen in Barrett's cell strains in vitro. These in vitro observations are analogous to the clinical progression to aneuploidy that often precedes cancer in Barrett's esophagus, and suggest that reactivation of telomerase may be permissive for continued genetic evolution to cancer. Long-lived Barrett's esophagus epithelial cultures should provide a useful in vitro model for studies of neoplastic evolution and chemopreventive therapies. FAU - Palanca-Wessels, M Corinna A AU - Palanca-Wessels MC AD - Department of Pathology, University of Washington, Seattle, Washington, USA. FAU - Klingelhutz, Aloysius AU - Klingelhutz A FAU - Reid, Brian J AU - Reid BJ FAU - Norwood, Thomas H AU - Norwood TH FAU - Opheim, Kent E AU - Opheim KE FAU - Paulson, Thomas G AU - Paulson TG FAU - Feng, Ziding AU - Feng Z FAU - Rabinovitch, Peter S AU - Rabinovitch PS LA - eng GR - R01 CA061202/CA/NCI NIH HHS/United States GR - R01 CA78855/CA/NCI NIH HHS/United States GR - T32 AG00057/AG/NIA NIH HHS/United States GR - R01 CA61202/CA/NCI NIH HHS/United States GR - T32 AG000057/AG/NIA NIH HHS/United States GR - P01 CA91955/CA/NCI NIH HHS/United States GR - P01 CA091955/CA/NCI NIH HHS/United States GR - P01 AG001751/AG/NIA NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. DEP - 20030509 PL - England TA - Carcinogenesis JT - Carcinogenesis JID - 8008055 RN - 0 (DNA-Binding Proteins) RN - EC 2.7.7.49 (Telomerase) SB - IM MH - Barrett Esophagus/*genetics/*pathology MH - Cell Adhesion MH - Cell Division MH - Cell Transformation, Neoplastic/*pathology MH - Chromosome Aberrations MH - Colony-Forming Units Assay MH - DNA-Binding Proteins MH - Epithelial Cells/pathology MH - Flow Cytometry MH - *Gene Expression Regulation, Enzymologic MH - Humans MH - In Situ Hybridization, Fluorescence MH - In Vitro Techniques MH - Karyotyping MH - Retroviridae/genetics MH - Telomerase/*genetics MH - Telomere/metabolism MH - Transduction, Genetic MH - Transfection PMC - PMC1559990 MID - NIHMS11541 EDAT- 2003/06/17 05:00 MHDA- 2003/08/23 05:00 PMCR- 2008/01/28 CRDT- 2003/06/17 05:00 PHST- 2003/06/17 05:00 [pubmed] PHST- 2003/08/23 05:00 [medline] PHST- 2003/06/17 05:00 [entrez] PHST- 2008/01/28 00:00 [pmc-release] AID - bgg076 [pii] AID - 10.1093/carcin/bgg076 [doi] PST - ppublish SO - Carcinogenesis. 2003 Jul;24(7):1183-90. doi: 10.1093/carcin/bgg076. Epub 2003 May 9.